Office Conversions Face Scrutiny After Pfizer HQ Incident
A buckling-column episode at the former Pfizer headquarters triggers renewed scrutiny of NYC office-to-residential pr...
Choosing the right rewards program can significantly impact your benefits. Learn which one suits you best.
27,839 articlesA buckling-column episode at the former Pfizer headquarters triggers renewed scrutiny of NYC office-to-residential pr...
Rocket Lab is shaping the small-launch landscape, and the company’s 2025 earnings story matters for investors. This g...
Today’s move in redwire stock popped today reflects a developing narrative around space infrastructure and NASA's new...
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...
A promised Europe adventure collapsed, leaving families with unrefunded costs. This guide explains restitution, red f...
Warren Buffett weighed social beliefs and offered practical ideas on how to shore up Social Security. This article br...
PennyMac’s Third-Party Origination unit rolls out a seven-program non-QM suite to broaden options for borrowers with ...
Federal actions against a Coca-Cola bottler and an EEOC inquiry into Nike signal a broader shift in how discriminatio...
A UK-listed bitcoin treasury company uncovers a counterintuitive edge: buying back its own stock can yield about 24% ...
If you’re seeking a single, enduring reason to own Lilly stock, this article lays it out. You’ll learn how a durable ...
Solana is often pitched as a blockchain that outpaces and underprices Ethereum. This article digs into why those adva...
Entrepreneurship powered America’s rise, and Steve Case argues we must expand that engine nationwide to guard the cou...